Volume 27, Issue 1 - Vaccines and Immunotherapies

Lay writing: Strategies for improving assent forms

Authors: Danielle Yuill, Rachel Barron, Jennifer Preston

Abstract

Download the full article

References

1. World Medical Association Declaration of Helsinki. JAMA. 2013;310(20):2191–4.
2. International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use. ICH Harmonised Tripartite Guideline. Clinical Investigation of Medicinal Products in the Pediatric Population (E11). 2000.
3. US Department of Health and Human Services. Code of Federal Regulations, Title 21 (Food and Drugs) Food and Drug Administration, Part 46 – Protection of Human Subjects, Subpart D, Section 46.408. Accessed 26 July 2016.
4. Giesbertz N, Bredenoord A, van Delden J. Clarifying assent in pediatric research. Eur J Hum Genet. 2013;22(2):266–9.
5. Lepola P, Needham A, Mendum J, Sallabank P, Neubauer D, de Wildt S. Informed consent for paediatric clinical trials in Europe: Table 1. Arch Dis Child. 2016;101(11):1017–25.
6. Calderón JL, Morales LS, Liu H, Hays RD. Variation in the readability of items within surveys. Am J Med Qual. 2006;21(1):49–56.
7. National Institute of Adult Continuing Education. Readability: how to produce clear written materials for a range of readers. Leicester: NIACE; 2009.
8. National Institute for Health Research. Medicines for Children Research Network. Guidance document for researchers designing patient information leaflets. Available from: http://www.hra-decisiontools.org.uk/consent/docs/MRCN%20YPAG%20-%20Guidance%20for%20Researchers%20designing%20Patient%20Information%20Leaflets.pdf
9. INVOLVE. Involving children and young people in research: top tips for researchers. Eastleigh: INVOLVE; 2016.
10. INVOLVE. Briefing notes for researchers: involving the public in NHS, public health and social care research. Eastleigh: INVOLVE; 2012.